Malawi Integrated HIV Program Report 2019 Q1

  • Scale-up of integrated HIV services had reached the following number of sites:
    • 759 static and 112 outreach HIV testing sites
    • 744 (static) ART sites; 636 of these started at least one pregnant or breastfeeding woman and 715 started symptomatic patients (Test & Treat) this quarter
    • 680 sites with HIV-exposed children in follow-up
  • 1,117,587__persons were tested for HIV and received their results; __247,550 (22%) accessed HIV testing for the first time; 870,037 (78%) were repeat testers and 35,483 (3%) of these received confirmatory testing (after having tested positive in the past). 32,313 (3%) clients received a positive result for the first time1.
  • 22,971 (89%) of 24,763 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.
  • 152,908 (98%) of 156,104 women at ANC had their HIV status ascertained; 10,973 (7%) of these were HIV positive. 129,526(95%) of 136,653 at maternity had their HIV status ascertained 10,018(8%) of these were HIV positive.
  • 41,868 patients started ART this quarter; 79% were classified as asymptomatic / in WHO stage 1 and started under the “Test & Treat” policy.
  • 810,245 patients were alive and on ART by end of March 2019. This means that 76% of the estimated 1,062,622 HIV positive population was on ART. 2 ART coverage was 64% (44,992 / 69,987) for children3 and 77% (765,253 / 992,635) for adults.
  • 76,326 (90%) of 85,127 viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates for routine samples among children (0-14 years) and adults (15+ years) were 59% and 92%, respectively.
  • 74% of adults and 79% of children were retained alive on ART at 12 months after initiation.
  • Out of 744,835 patients on first line adult ART 427,130 (57%) were on TDF/3TC/EFV and 284,816 (38%) had transitioned to TDF/3TC/DTG.
  • 13,000 5 (119%) of an estimated 10,932 2 HIV infected pregnant women in Malawi were on ART this quarter. 9,312(72%) of these were already on ART when getting pregnant and 3,688 (28%) started ART during pregnancy/delivery.
  • An additional 1,480 breastfeeding women started ART in WHO stage 1 or 2.
  • 75%, 71% of women started while pregnant or breastfeeding were retained on ART at 6 and 12 months after initiation, respectively.
  • 9,377 (8%) of infants discharged alive from maternity were known to be HIV exposed, 9,086 (96%) of these received ARV prophylaxis (nevirapine).

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2019
Author
Author Email cmkandawire@hivmw.org
Visibility